Investment
Features
FeesSafety
Academy
More
Pluang+

Compare JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) vs Tilray Brands Inc (TLRY) Price & Performance

JPMorgan Nasdaq Equity Premium Income ETFTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

JPMorgan Nasdaq Equity Premium Income ETF vs Tilray Brands Inc — how do they compare? JPMorgan Nasdaq Equity Premium Income ETF trades at $60.06, while Tilray Brands Inc trades at $4.73 (market cap $649.42M). The key difference: JPMorgan Nasdaq Equity Premium Income ETF is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.

JEPQTLRY
Sector
Income / Options OverlayHealth
52-Week High
$61.46$21.00
52-Week Low
$53.77$3.88
Market Cap
$649.42M
Enterprise Value
$816.55M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

JPMorgan Nasdaq Equity Premium Income ETF

JEPQ trades at $60.055, up 0.63% with a bullish technical signal from moving averages. The ETF's covered-call strategy generates consistent monthly income, with recent dividends of $0.70, $0.64, and $0.56. News coverage highlights its role in retirement income strategies alongside tax considerations for distributions. Institutional interest remains strong with Bank of America increasing its stake by 8.9% in Q1 2026.

JEPQ offers attractive yield generation through its Nasdaq-focused options strategy, but investors face tax implications as distributions are taxed as ordinary income. The ETF's performance depends on market volatility for premium collection, creating both opportunity and risk during turbulent periods. Current technical strength supports near-term upside potential.

Tilray Brands Inc

TLRY trades at $4.77, up 7.92% in the last session, with a bullish technical signal from moving averages but mixed oscillators. The company reported record fiscal 2026 revenue of $915 million (GlobeNewsWire, July 28, 2026) but posted a net loss. Key financials show a low P/S of 0.58 and P/B of 0.4, yet profitability remains challenged with negative net income margins and ROE.

Outlook is cautiously optimistic due to revenue growth and diversification into beverages and wellness, but high execution risk persists from consistent losses and competitive pressures. Analyst sentiment is mixed with 25% buy ratings, suggesting potential upside if profitability improves, though near-term volatility is likely.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About JPMorgan Nasdaq Equity Premium Income ETF

JEPQ seeks to provide monthly income and exposure to the Nasdaq-100 Index with less volatility. It uses a methodology that combines high-growth tech stocks with an options strategy to capture income.

Read more on JEPQ

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY